| 4 | Statement of changes in beneficial owner... | Ascendis Pharma A/s | Latham & Watkins Llp (filing Agent) /fa | 05/12/2026 | |
| 4 | Statement of changes in beneficial owner... | Jensen Flemming Steen | Latham & Watkins Llp (filing Agent) /fa | 05/12/2026 | |
| 3 | Initial statement of beneficial ownershi... | Jensen Flemming Steen | Latham & Watkins Llp (filing Agent) /fa | 03/18/2026 | |
| 3 | Initial statement of beneficial ownershi... | Ascendis Pharma A/s | Latham & Watkins Llp (filing Agent) /fa | 03/18/2026 | |
| 144 | Filing for proposed sale of securities u... | Ascendis Pharma A/s | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 09/09/2025 | |
| 144 | Filing for proposed sale of securities u... | Jensen Flemming Steen | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 09/09/2025 | |
| 144 | Filing for proposed sale of securities u... | Jensen Flemming Steen | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 08/13/2025 | |
| 144 | Filing for proposed sale of securities u... | Ascendis Pharma A/s | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 08/13/2025 | |
| 144 | Filing for proposed sale of securities u... | Jensen Flemming Steen | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 05/07/2025 | |
| 144 | Filing for proposed sale of securities u... | Ascendis Pharma A/s | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 05/07/2025 | |
| Load More |
